Scientific Information
Scientific Information About Miscletoe (Viscum Album) Therapy
● What does a therapy do? How safe are we? Where do we get our knowledge from? If we want to form our own judgement about this therapy, we need the results of scientific investigations. But scientific information is constantly increasing and the results are scattered and often difficult to obtain. This website provides an up-to-date overview of scientific studies on the clinical use of Mistletoe (Viscum Album) therapy in cancer.
● Our information platform is aimed at physicians, scientists, journalists, representatives from politics, self-government and health insurances as well as at interested students and also at patients who want to orientate themselves on the current state of clinical research and important clinical observations. These information pages are prepared and compiled according to scientific criteria. They do not contain any kind of advertisement for any preparations or companies.
● These information pages are prepared and compiled according to scientific criteria. They do not contain any kind of advertisement for any preparations or companies.

Integrative | Conventional |
---|---|
The necessity for cancer patients requires locating the best available interventions to improve quality of life and cancer survival. | conventional cancer care focuses on conventional cancer treatments with therapies such as surgery, radiation, chemotherapy, molecular targets, and other potential interventions |
Integrative cancer care combines conventional cancer treatments with whole person health and healing | Conventional cancer care treats the disease and not the whole person. |
Testimonials

MR. F V
10 October 2020
My name is F.V and this is regarding my 68 year old mother, a cervical cancer patient who is currently undergoing treatment under the expertise of Dr Sandeep Roy in Nashik-India. I would like to share a detailed testimony and positive results we have seen with Dr Sandeep Roy mistletoe therapy mode of treatment…

MR. D P
10 October 2020

MR. D P
10 October 2020
BOOK AN
APPOINTMENT
Patients with late-stage non-small cell lung cancer (NSCLC) receiving supplementary mistletoe treatment in addition to chemotherapy were able to survive significantly longer than patients receiving chemotherapy alone, a new observational study has found.